SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-111584
Filing Date
2024-10-28
Accepted
2024-10-28 06:00:28
Documents
2
Group Members
ALEXION PHARMACEUTICALS, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2426761d1_sc13g.htm SC 13G 57380
2 EXHIBIT A tm2426761d1_ex-a.htm EX-99.A 3416
  Complete submission text file 0001104659-24-111584.txt   62629
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Subject) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94081 | Film No.: 241398269
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)